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In Figures 2e, 6e and 7d, the Y axis scale is incorrect. The correct Figures appear below as Figures 1, 2 and 3.
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Figure 1. Nod2−/− mice on HFD develop steatosis and have large stressed adipocytes with increased infiltration 
of macrophages. (A,B) Liver sections from Nod2−/− and WT mice stained with (A) H&E or (B) BODIPY and 
DAPI. (C) Percent frequency distribution of the area (μm2) of ~5,000 LDs/group. (D,E) Quantification of 
liver cholesterol and triglycerides. (F) Heatmap representation of the fold increase (red) or decrease (green) 
in the abundance of proteins present in LD-enriched fraction from liver. The fold ratio for individual Nod2−/− 
HFD mice to the average of WT HFD mice were computed (lanes 1 to 5) with the average of the fold for all 
Nod2−/− HFD mice. (G) Adipose tissue H&E sections and a dying cell (→) is indicated. (H) Percent frequency 
distribution the area of ~8,000 adipocytes/group. (I) Average numbers of dying adipocytes (crowns) per 3,000 
cells in H&E stained sections. (J) Quantification of CD45+F4/80+ macrophage in adipose tissue. (K–M) 
Transcript levels for Adgre1, Cd68, and Tnfα in adipose tissue. Images are representative and results are (C,H,I) 
means ± SEM of 6 mice/group and (D,E,J–M) for individual mice with N = 5–10 mice/group. *P ≤ 0.05, **P 
≤ 0.001, Nod2−/− HFD versus WT HFD; #P ≤ 0.05, ##P ≤ 0.001, Nod2−/− HFD versus Nod2−/− LFD; ^P ≤ 0.05, 
WT HFD versus WT LFD; and +P ≤ 0.05, Nod2−/− LFD versus WT LFD.
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Figure 2. Antibiotic treatment prevents the development of obesity, steatosis, and metabolic dysfunction in 
Nod2−/− mice on HFD. (A) Nod2−/− and WT mice were treated with Abx to deplete their intestinal microbiota. 
Control mice were not treated with antibiotics. Three weeks after the start of Abx all mice were placed on HFD 
and monitored for weight gain, histopathology, and metabolites. (B) Percent gain in weight compared to week 
0 of HFD. (C,D) After 14 weeks of HFD, mice were analyzed for liver histopathology in BODIPY and DAPI 
stained sections and (D) percent frequency distribution of LD area (μm2) for ~4,000 LDs/group. (E–H) After 14 
weeks of HFD, (E) liver triglycerides, (F) liver cholesterol, (G) serum cholesterol, and (H) serum triglycerides 
were measured. (B,D) Results are means ± SEM, (C) representative images, and (E–H) individual data of 6–10 
mice/group. *P ≤ 0.05 and **P ≤ 0.001, Nod2−/− Abx + HFD versus Nod2−/− HFD.
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Figure 3. Intestinal microbiota from Nod2−/− mice on HFD increases susceptibility of germ-free mice to 
HFD-induced obesity and metabolic dysfunction. (A) One week before delivery, we colonized germ-free WT 
Swiss Webster female pregnant mice, kept under sterile conditions, with microbiota from WT or Nod2−/− 
mice maintained on HFD. Colonization was done by both gavaging with fecal microbiota and by co-housing. 
Gavaging was done into the stomach with fecal homogenates from WT or Nod2−/− mice maintained on HFD 
(indicated by ↑). At the same time, the gavaged mice were placed on HFD and also co-housed with Nod2−/− or 
WT female mice that had been maintained on HFD for ~20 weeks. The co-housed Nod2−/− HFD and WT 
HFD mice were removed when the pups were born (week 0). Mothers and pups were maintained on HFD for 
the length of the experiment. (B–E) Pups were monitored for (B) gain in weight every week and after 8 weeks 
assayed for (C) liver cholesterol, (D) liver triglycerides and (E) serum glucose. (B) Results are means ± SEM 
and (C–E) individual data of 19–21 mice/group. *P ≤ 0.05 and **P ≤ 0.001, Nod2−/− Abx + HFD versus 
Nod2−/− HFD.
